Biosig Technologies (BSGM) Competitors $5.46 +0.23 (+4.40%) Closing price 04:00 PM EasternExtended Trading$5.44 -0.02 (-0.44%) As of 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BSGM vs. TNDM, FNA, BLFS, LQDA, SSII, PLSE, INMD, MDXG, KMTS, and SIBNShould you be buying Biosig Technologies stock or one of its competitors? The main competitors of Biosig Technologies include Tandem Diabetes Care (TNDM), Paragon 28 (FNA), BioLife Solutions (BLFS), Liquidia Technologies (LQDA), SS Innovations International (SSII), Pulse Biosciences (PLSE), InMode (INMD), MiMedx Group (MDXG), Kestra Medical Technologies (KMTS), and SiBone (SIBN). These companies are all part of the "medical equipment" industry. Biosig Technologies vs. Its Competitors Tandem Diabetes Care Paragon 28 BioLife Solutions Liquidia Technologies SS Innovations International Pulse Biosciences InMode MiMedx Group Kestra Medical Technologies SiBone Tandem Diabetes Care (NASDAQ:TNDM) and Biosig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership. Is TNDM or BSGM more profitable? Biosig Technologies has a net margin of 0.00% compared to Tandem Diabetes Care's net margin of -18.71%. Tandem Diabetes Care's return on equity of -57.33% beat Biosig Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Tandem Diabetes Care-18.71% -57.33% -13.48% Biosig Technologies N/A -5,336.99%-398.16% Which has more risk & volatility, TNDM or BSGM? Tandem Diabetes Care has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500. Comparatively, Biosig Technologies has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500. Does the media favor TNDM or BSGM? In the previous week, Tandem Diabetes Care had 1 more articles in the media than Biosig Technologies. MarketBeat recorded 11 mentions for Tandem Diabetes Care and 10 mentions for Biosig Technologies. Tandem Diabetes Care's average media sentiment score of 0.85 beat Biosig Technologies' score of 0.75 indicating that Tandem Diabetes Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Biosig Technologies 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in TNDM or BSGM? 7.2% of Biosig Technologies shares are held by institutional investors. 1.9% of Tandem Diabetes Care shares are held by company insiders. Comparatively, 17.0% of Biosig Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has higher valuation and earnings, TNDM or BSGM? Biosig Technologies has lower revenue, but higher earnings than Tandem Diabetes Care. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTandem Diabetes Care$982.95M1.07-$96.03M-$2.78-5.67Biosig Technologies$40K3,726.45-$10.33MN/AN/A Do analysts rate TNDM or BSGM? Tandem Diabetes Care presently has a consensus price target of $32.71, indicating a potential upside of 107.71%. Biosig Technologies has a consensus price target of $10.00, indicating a potential upside of 83.15%. Given Tandem Diabetes Care's higher possible upside, equities research analysts clearly believe Tandem Diabetes Care is more favorable than Biosig Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 1 Sell rating(s) 8 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33Biosig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryTandem Diabetes Care and Biosig Technologies tied by winning 7 of the 14 factors compared between the two stocks. Get Biosig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBiosig TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$149.06M$6.68B$5.53B$9.13BDividend YieldN/A1.28%5.06%4.01%P/E RatioN/A26.3228.5819.57Price / Sales3,726.4564.64372.6479.65Price / CashN/A20.6824.7227.51Price / Book-60.674.728.235.56Net Income-$10.33M$174.76M$3.19B$252.37M7 Day Performance-52.73%1.46%5.46%3.11%1 Month Performance-14.55%2.12%9.39%11.74%1 Year Performance1,200.00%7.31%30.48%17.41% Biosig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBiosig Technologies1.9454 of 5 stars$5.46+4.4%$10.00+83.2%+1,145.2%$149.06M$40K0.0050News CoverageGap DownHigh Trading VolumeTNDMTandem Diabetes Care4.2091 of 5 stars$16.25-3.2%$33.43+105.7%-66.2%$1.12B$940.20M-5.852,650Positive NewsFNAParagon 28N/A$13.11+0.1%$12.75-2.7%+72.9%$1.10B$256.18M-17.71343,000High Trading VolumeBLFSBioLife Solutions2.1867 of 5 stars$21.81-4.5%$31.17+42.9%+5.9%$1.08B$82.25M-75.20440LQDALiquidia Technologies3.1532 of 5 stars$12.45+2.1%$26.89+116.0%+11.7%$1.04B$14M-7.8850SSIISS Innovations InternationalN/A$5.27-1.3%N/AN/A$1.03B$20.65M0.004Gap UpPLSEPulse Biosciences3.8513 of 5 stars$15.81+3.3%$22.00+39.2%-13.7%$1.03B$700K0.00140INMDInMode4.1124 of 5 stars$15.10-0.4%$18.54+22.8%-17.7%$958.25M$394.82M6.48480Analyst ForecastMDXGMiMedx Group3.814 of 5 stars$6.48+2.2%$12.50+92.9%-6.6%$936.43M$348.88M24.00870Positive NewsKMTSKestra Medical TechnologiesN/A$14.75-5.9%$27.50+86.4%N/A$804.64M$52.64M0.00300SIBNSiBone3.9875 of 5 stars$18.01-2.5%$22.50+24.9%+12.3%$787.09M$167.18M-28.14350News CoveragePositive News Related Companies and Tools Related Companies Tandem Diabetes Care Competitors Paragon 28 Competitors BioLife Solutions Competitors Liquidia Technologies Competitors SS Innovations International Competitors Pulse Biosciences Competitors InMode Competitors MiMedx Group Competitors Kestra Medical Technologies Competitors SiBone Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
